{"nct_id":"NCT03255382","title":"A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy","status":"COMPLETED","status_verified_date":"2019-08","start_date":"2017-08-22","start_date_type":"ACTUAL","primary_completion_date":"2018-07-06","primary_completion_date_type":"ACTUAL","completion_date":"2018-07-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}